InvestorsHub Logo
Followers 839
Posts 120482
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Sunday, 09/20/2020 1:47:05 PM

Sunday, September 20, 2020 1:47:05 PM

Post# of 875
MRK’s ESMO data for early-stage pipeline—Vibostolimab/MK-7684 (anti-TIGIT); MK-4830 (anti-ILT4); and MK-6482 (HIF-2alpha inhibitor):

https://www.businesswire.com/news/home/20200920005057/en

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News